BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 3 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $970,803 | -23.3% | 40,366 | +1.9% | 0.00% | -50.0% |
| Q2 2023 | $1,264,907 | -53.2% | 39,615 | -55.2% | 0.00% | -33.3% |
| Q1 2023 | $2,705,338 | -21.8% | 88,352 | -0.1% | 0.00% | -40.0% |
| Q4 2022 | $3,458,966 | -17.3% | 88,442 | +0.8% | 0.01% | -16.7% |
| Q3 2022 | $4,180,124 | +45.0% | 87,744 | +17.8% | 0.01% | -14.3% |
| Q2 2022 | $2,882,000 | -16.5% | 74,459 | +23.6% | 0.01% | 0.0% |
| Q1 2022 | $3,452,000 | -30.8% | 60,244 | -3.8% | 0.01% | -30.0% |
| Q4 2021 | $4,992,000 | -61.4% | 62,637 | -57.9% | 0.01% | -61.5% |
| Q3 2021 | $12,935,000 | +443.7% | 148,652 | +704.2% | 0.03% | +420.0% |
| Q2 2021 | $2,379,000 | +70.1% | 18,484 | +5.7% | 0.01% | +66.7% |
| Q1 2021 | $1,399,000 | +0.9% | 17,480 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $1,387,000 | +385.0% | 16,991 | +46.2% | 0.00% | +200.0% |
| Q3 2020 | $286,000 | – | 11,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |